Antihypertensives Flashcards
Thiazide diuretics (2)
HYDROCHLOROTHIAZIDE, and CHLORTHALIDONE
Loop diuretic
Furosemide
Aldosterone Antagonists
Spironolactone
ACE inhibitor
Captopril
ARBs
Losartan
Direct renin inhibitors
Aliskiren
Calcium Channel Blockers
Dihydropyridine: Nifedipine
Non-Dihydropyridines: Verapamil, Diltiazem
Vasodilators
Nitroprusside, hydralazine, minoxidil
Sympatholytics
1) Clonidine, methyldopa: Centrally acting alpha-2 adrenergic agonists.
2) Beta blockers (Propranolol, metoprolol, atenolol).
3) Alpha Blockers (terazosin)
First-line agents for HTN
Thiazide diuretics, ACE inhibitors or ARBs, CCBs
Third-line agents for HTN
Loop diuretics, aliskiren, alpha-1 blockers, vasodilators, central alpha-2 aonists, reserpine, aldosterone antagonists, beta blockers
MOA of hydrochlorothiazide and chlorothalidone
1) Initially descreses vascular volume and CO via its direct diuresis effect (inhibits NA-Cl symporter in DCT)
2) Long term- indirectly decreases TPR- mechanism unclear
For thiazide diuretics, you only need a low dose (12.5-25 mg). Why is that?
Doses >25 mg provide no further benefit but increases risks and adverse effects. Low dose used as monotherapy for stage 1; lowers BP 10-15 mm in most patients 4-6 after onset of therapy.
Thiazide diuretics are used with other antihypertensives how?
In combination due to a synergistic effect and to reduce Na+/water retention caused by vasodilators and sympatholytics.
hydrochlorothiazide vs. chlorothalidone: Which drug is less potent and has a shorter duration of action yielding lower efficacy in controlling nocturnal BP?
hydrochlorothiazide
hydrochlorothiazide vs. chlorothalidone: Which drug may be inferior in reducing the risk of CV events?
hydrochlorothiazide
Adverse effects of Thiazide diuretics?
1) Hypokalemia
2) Hyperuricemia (gout), hyperglycemia, hyperlipidemia
3) Erectile dysfunction
Drug and MOA for loop diuretics
Furosemide: decrease CO by reducing volume overload- blocks Na-Cl-K symporter in ascending limb of henle’s loop
When is furosemide mostly used?
For malignant HTN and volume-dependent patients with renal disease.
Name an Aldosterone Antagonist and its MOA:
Spironolactone: Decreases CO by reducing volume overload. 1) Blocks aldosterone receptors in collecting duct of epithelial cells. 2) Prevents cardiovascular remodeling.
Adverse effects for Spironolactone:
Hyperkalemia, Gynecomastia, impotence, hirsutism
Name an ACE inhibitor and the MOA:
Captopril: Decrease TPR
1) Inhibits enzymatic conversion of AngI to AngII (vasoconstrictor) and degradation of bradykinin (vasodilator).
2) Reduces stimulation of both AngII AT1 and AT2 receptors
3) Decreases AngII-mediated cardiovascular remodeling and renal dysfunction
Anti-HTN uses for Captopril:
1) Monotherapy for stage 1; lowers BP even in patients with normal Plasma renin activity.
2) In combination with other anti-HTN; mitigates the risk of hypokalemia from thiazide diuretic therapy
True/False: Ace inhibitors have no interference with cardiovascular reflexes- exercise capacity is not impaired and orthostatic Hypotension is minimal
TRUE- this is a clinical advantage over 2nd-line drugs